Evidence map›Paper›PMID 30501072›Full record

ArticleInternational journal of molecular sciences2018

Development of Spermatogenesis In Vitro in Three-Dimensional Culture from Spermatogonial Cells of Busulfan-Treated Immature Mice.

Ali AbuMadighem, Ronnie Solomon, Alina Stepanovsky, Joseph Kapelushnik, QingHua Shi, Eckart Meese, Eitan Lunenfeld, Mahmoud Huleihel

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Recent Progress of Induced Spermatogenesis In Vitro.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Recent Progress of In Vitro 3D Culture of Male Germ Stem Cells.Journal of functional biomaterials · 2023
    Review
  10. Review
  11. In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Ali AbuMadighemThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Beer-Sheva 84105, Israel. abumadig@post.bgu.ac.il.
Ronnie SolomonThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Beer-Sheva 84105, Israel. ronnieso@post.bgu.ac.il.
Alina StepanovskyThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Beer-Sheva 84105, Israel. alinaste@post.bgu.ac.il.
Joseph KapelushnikThe Center of Advanced Research and Education in Reproduction (CARER), Faculty of Health Sciences, Beer-Sheva 8410501, Israel. kapelush@bgu.ac.il.
QingHua ShiMolecular and Cell Genetics Laboratory, The CAS Key Laboratory of Innate Immunity and Chronic Disease, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei 230000, China. qshi@ustc.edu.cn.
Eckart MeeseInstitute of Human Genetics, Saarland University, Homburg/Saar, 66421 Homburg, Germany. eckart.meese@uks.eu.
Eitan LunenfeldThe Center of Advanced Research and Education in Reproduction (CARER), Faculty of Health Sciences, Beer-Sheva 8410501, Israel. lunenfld@bgu.ac.il.
Mahmoud HuleihelThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Beer-Sheva 84105, Israel. huleihel@bgu.ac.il.
Ben-Gurion University of the Negev · ILSaarland University · DEUniversity of Science and Technology of China · CN

Funding

The Israel Science Foundation 295/14The Kahn Foundation 0000The United States-Israel Binational Science Foundation (BSF). 2011-111
6 · The paper itself

Abstract

Aggressive chemotherapy may lead to permanent male infertility. Prepubertal males do not generate sperm, but their testes do contain spermatogonial cells (SPGCs) that could be used for fertility preservation. In the present study, we examined the effect of busulfan (BU) on the SPGCs of immature mice, and the possible induction of the survivor SPGCs to develop spermatogenesis in 3D in-vitro culture. Immature mice were injected with BU, and after 0.5⁻12 weeks, their testes were weighed and evaluated histologically compared to the control mice. The spermatogonial cells [Sal-like protein 4 (SALL4) and VASA (a member of the DEAD box protein family) in the testicular tissue were counted/seminiferous tubule (ST). The cells from the STs were enzymatically isolated and cultured in vitro. Our results showed a significant decrease in the testicular weight of the BU-treated mice compared to the control. This was in parallel to a significant increase in the number of severely damaged STs, and a decrease in the number of SALL4 and VASA/STs compared to the control. The cultures of the isolated cells from the STs of the BU-treated mice showed a development of colonies and meiotic and post-meiotic cells after four weeks of culture. The addition of homogenates from adult GFP mice to those cultures induced the development of sperm-like cells after four weeks of culture. This is the first study demonstrating the presence of biologically active spermatogonial cells in the testicular tissue of BU-treated immature mice, and their capacity to develop sperm-like cells in vitro.

Indexed as

AnimalsBusulfanCell DifferentiationCells, CulturedDEAD-box RNA HelicasesDNA-Binding ProteinsInfertility, MaleMaleMiceSeminiferous TubulesSpermatogenesisSpermatogoniaTestisTranscription FactorsBusulfanDdx4 protein, mouseDEAD-box RNA HelicasesDNA-Binding ProteinsSall4 protein, mouseTranscription Factorschemotherapymale infertilityspermatogenesisspermatogonial cellstestisthree-dimensional culture

Identifiers

PMID30501072
PMCPMC6321353
OpenAlexW2902078101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.